118 results
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties … for the purpose of updating such description.
You may obtain copies of these documents on the website maintained by the SEC at http://www.sec.gov, or from us
8-K
EX-4.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value … hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights
8-K
EX-4.5
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior … for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
8-K
EX-10.3
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non … -employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion
8-K
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
, including, in some cases, for the purpose of allocating risk among the parties to such agreements. In addition, the assertions embodied in any
8-K
EX-4.2
zwomobdax4cx884c4
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.4
jghcejdp544h41w
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.1
6uyijx 3fubkgt6
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.2
q6yeq576f 9hbec
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.3
a9ibxpawbur
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
424B5
w456roh
20 May 24
Prospectus supplement for primary offering
7:09am